Neal Hermanowicz

picture of Neal  Hermanowicz

Health Sciences Clinical Professor, Neurology
School of Medicine
Director, UC Irvine Movement Disorders Program

Director, Phillip & Carol Traub Center for Parkinson's and Movement Disorders, Eisenhower Medical Center

Affiliate Faculty, UCI Institute for Memory Impairments and Neurological Disorders (MIND)

B.S., University of Illinois, Champaign-Urbana, Chemistry

M.D., Temple University School of Medicine

Phone: (949) 824-0190

University of California, Irvine
100 Irvine Hall
Irvine, CA 92697
Research Interests
Movement Disorders, including Parkinson's disease, Huntington's disease, Dystonia
Academic Distinctions
Physician of Excellence-Orange Coast Magazine/Orange County Medical Association
Top Doctor-Palm Springs LIfe Magazine
Physician of Excellence-Dystonia Medical Research Foundation
1: Solbrig MV, Fan Y, Hermanowicz N, Morgese MG, Giuffrida A. A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats. Exp Neurol. 2010 Nov;226(1):231-41.
2: Cramer SC, Sampat A, Haske-Palomino M, Nguyen S, Procaccio V, Hermanowicz N. Increased prevalence of val(66)met BDNF genotype among subjects with cervical dystonia. Neurosci Lett. 2010 Jan 1;468(1):42-5.
3: Aurora SK, Dodick DW, Turkel CC, DeGryse RE, Silberstein SD, Lipton RB, Diener HC, Brin MF; PREEMPT 1 Chronic Migraine Study Group. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia. 2010 Jul;30(7):793-803.
4: Lyons KE, Friedman JH, Hermanowicz N, Isaacson SH, Hauser RA, Hersh BP, Silver DE, Tetrud JW, Elmer LW, Parashos SA, Struck LK, Lew MF, Pahwa R. Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects. Clin Neuropharmacol. 2010 Jan-Feb;33(1):5-10.
5: Olanow CW, Rascol O, Hauser R, Feigin PD, Jankovic J, Lang A, Langston W, Melamed E, Poewe W, Stocchi F, Tolosa E; ADAGIO Study Investigators. A double-blind, delayed-start trial of rasagiline in Parkinson's disease. N Engl J Med. 2009 Sep 24;361(13):1268-78.
Professional Societies
Movement Disorders Society, American Academy of Neurology
Parkinson Study Group, Huntington Study Group, Dystonia Study Group
Multiple Systems Atrophy Study Group
Other Experience
Internal Medicine
University of Wisconsin Hospitals and Clinics 1985—1986

Neurology Residency
University of Wisconsin Hospitals and Clinics 1986—1989

Chief Resident, Neurology
University of Wisconsin Hospitals and Clinics 1988—1989

Fellow, Movement Disorders
University of Michigan 1989—1991

Graduate Programs

Last updated